Tapering and withdrawal of tocilizumab in patients with systemic juvenile idiopathic arthritis in inactive disease: results from an alternative dosing regimen in the TENDER study
Crossref DOI link: https://doi.org/10.1186/1546-0096-12-S1-O13
Published Online: 2014-09-17
Published Print: 2014-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
De Benedetti, F
Ruperto, N
Brunner, H
Grom, A
Wulffraat, N
Henrickson, M
Jerath, R
Kimura, Y
Kadva, AK
Wang, J
Martini, A
Lovell, D
Article History
First Online: 17 September 2014